Clinical • Metastases
|
BRCA1 (Breast cancer 1, early onset) • BRCA2 (Breast cancer 2, early onset) • PALB2 (Partner and localizer of BRCA2) • RAD51C (RAD51 paralog C) • RAD51D (RAD51 paralog D)
|
BRCA2 mutation • BRCA1 mutation • PALB2 mutation • RAD51C mutation • RAD51 mutation
|
Lynparza (olaparib) • Talzenna (talazoparib)